Cargando…
A Propensity-Matched Analysis of Survival of Clinically Diagnosed Early-Stage Lung Cancer and Biopsy-Proven Early-Stage Non-Small Cell Lung Cancer Following Stereotactic Ablative Radiotherapy
PURPOSE: Stereotactic body radiotherapy (SBRT) has been increasingly regarded as a reasonable option for early-stage lung cancer patients without pretreatment pathologic results, but the efficacy and safety in a Chinese population remains unclear. The aim of this study was to compare survival outcom...
Autores principales: | Zhang, Ran, Guo, Yanling, Yan, Yujie, Liu, Yuanjun, Zhu, Yaoyao, Kang, Jingjing, Li, Fangjuan, Sun, Xiaojiang, Xing, Ligang, Xu, Yaping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421845/ https://www.ncbi.nlm.nih.gov/pubmed/34504798 http://dx.doi.org/10.3389/fonc.2021.720847 |
Ejemplares similares
-
Stereotactic body radiotherapy for early stage non-small cell lung cancer in patients with subclinical interstitial lung disease
por: Liu, Yuanjun, et al.
Publicado: (2020) -
Five-year follow-up after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer: a multicenter study
por: Guo, Yanling, et al.
Publicado: (2023) -
SBRT for early stage lung cancer: outcomes from biopsy-proven and empirically treated lesions
por: Wegner, Rodney E, et al.
Publicado: (2018) -
Comparison of stereotactic body radiotherapy and radiofrequency ablation for early-stage non-small cell lung cancer: a systematic review and meta-analysis
por: Zhang, Ran, et al.
Publicado: (2022) -
Four-year follow-up outcomes after stereotactic body radiation therapy for central early-stage non-small cell lung cancer
por: Sun, Xiaojiang, et al.
Publicado: (2020)